Johnson & Johnson
-
Should Canadians still use nasal decongestants? What we know after FDA panel rulingThe Food and Drug Administration (FDA) ruled Tuesday that a key drug in popular decongestants is ineffective, which one Canadian group of doctors has known for years.CanadaSep 13
-
New blood cancer therapy approved in the U.S.The therapy's approval comes with FDA's "boxed" safety warning, flagging the risk of a type of aggressive immune response and neurologic toxicity.HealthAug 10
-
Some kids’ painkillers in short supply, but pharmacists say prescription not neededTwo Ontario pediatric hospitals say they're facing shortages of common pain relievers amid supply disruptions in some parts of the country.HealthAug 17, 2022
![]()
-
Johnson & Johnson to halt worldwide sales of talc-based baby powder in 2023The company faces about 38,000 lawsuits from consumers and their survivors claiming its talc products caused cancer due to contamination with asbestos, a known carcinogen.HealthAug 11, 2022
![]()
-
Canada won’t limit J&J COVID-19 vaccine access due to rare blood clots: TamCanada's top doctor said Friday that there have been no cases of a rare blood clotting syndrome from Johnson & Johnson's COVID-19 vaccine so far in the country.CanadaMay 6, 2022
![]()
-
U.S. First Nations win $590M from drug companies in opioid epidemic lawsuit settlementUnder the settlement, Johnson & Johnson agreed to pay $150 million over two years and the three largest U.S. drug distributors will pay nearly $440 million over seven years.WorldFeb 2, 2022
![]()
-
J&J expects COVID-19 vaccine sales boost in 2022 on strong demandJohnson & Johnson is expecting that sales of its COVID-19 vaccines could rise to $3.5 billion in 2022, though the total will not account for much of its overall profits.EconomyJan 25, 2022
![]()
-
J&J COVID-19 vaccine protects against breakthrough infections, study saysJohnson & Johnson said protection against COVID-19 infection from its single-dose vaccine starts to wane only from the fourth month.HealthJan 6, 2022
![]()
-
Single-dose Johnson & Johnson vaccine available in Sask. beginning WednesdayThe Saskatchewan government announced Tuesday that a supply of the one-dose J&J COVID-19 shot will be administered through multiple SHA clinics on a first-come, first-serve basis.HealthNov 16, 2021
![]()
-
COVID-19 vaccine maker Johnson & Johnson splitting into two companiesJohnson & Johnson, a medical manufacturing titan and COVID-19 vaccine maker, has announced it is dividing its business into two companies for better market impact.WorldNov 12, 2021
![]()
